Omer N. Koc
Hematology Oncology
26900 Cedar Rd
Beachwood, OH 44122
Beachwood, OH 44122
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Lenalidomide, rituximab (R2), and ixazomib for frontline treatment of high risk follicular and indolent non-Hodgkin lymphoma.
Journal: Leukemia & lymphoma
Published: March 08, 2024
Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia.
Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia.
Journal: The Laryngoscope
Published: November 10, 2017
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies.
Journal: Cancer chemotherapy and pharmacology
Published: September 28, 2011
Showing 1-3 of 3
Last Updated: 09/26/2026